News
On 2 March 2023, Robert Jehan and Dr Ryan Abbott will appear before the Supreme Court of the United Kingdom to argue that the Patents Act 1977 can permit the granting of patents for the DABUS patent applications. The appellant, Dr Thaler, created an ...
The Enlarged Board of Appeal at the European Patent Office (EPO) has now issued its written decision in consolidated cases G1/22 and G2/22. The Enlarged Board of Appeal concludes that the EPO is competent to assess priority entitlement and that there...
The EPO's idiosyncratic "ten day rule" relevant to calculating notified deadlines is being abolished in November. Many a European patent attorney has been thankful for the EPO's ten day rule after receipt of very late instructions to procee...
The long-awaited Enlarged Board of Appeal decision G2/21 has finally been issued. It confirms that evidence submitted in support of inventive step cannot be disregarded solely on the ground that such evidence had not been public before the filin...
The patenting of proteins is well established in Europe as long as they meet the requirements of novelty and inventive step.Antibodies are a specific type of protein, and to obtain useful patent protection for these, there are specific requirements t...
©
2007 - 2022
Williams Powell
All rights reserved.
Williams Powell are regulated by IPREG whose code of conduct can be found here.These pages aim to provide a source of information for both non-professional enquirers e.g. inventors and their companies in the U.K. and professional consultants and advisers throughout the rest of the world. The pages are not intended to provide legal advice, which will only be provided on direct application to us in the formal context of a client/attorney relationship.
The information provided is correct to the best of our knowledge and belief, but is provided without obligation or guarantee. It will be updated from time to time as needed.